SQZ Biotechnologies Revenue 2020-2023 | SQZ
SQZ Biotechnologies revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
SQZ Biotechnologies Annual Revenue
(Millions of US $) |
| 2022 |
$21 |
| 2021 |
$27 |
| 2020 |
$21 |
| 2019 |
$20 |
SQZ Biotechnologies Quarterly Revenue
(Millions of US $) |
| 2023-03-31 |
|
| 2022-12-31 |
$12 |
| 2022-09-30 |
$3 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$3 |
| 2021-12-31 |
$12 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$6 |
| 2020-06-30 |
$6 |
| 2020-03-31 |
$6 |
| 2019-12-31 |
|
| 2019-09-30 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.017B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
